Tag: locoregionally advanced nasopharyngeal carcinoma

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Sintilimab improves survival in advanced non-metastatic nasopharyngeal carcinoma

byNeel Mistryand1 others

July 30, 2024

1. Patients in the sintilimab group reported a significantly greater event-free survival at 36 months compared to the standard therapy ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Large language models (LLMs) demonstrated the ability to generate accurate research manuscripts but required human oversight for more complex analyses
Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases
The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

No Result

View All Result

Tag: locoregionally advanced nasopharyngeal carcinoma

Sintilimab improves survival in advanced non-metastatic nasopharyngeal carcinoma

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits